Literature DB >> 9372582

Periurethral collagen injection for male and female sphincteric incontinence: indications, techniques, and result.

E J McGuire1, S F English.   

Abstract

Intrinsic sphincter deficiency is characterized by a poorly functioning intrinsic urethral sphincter, which leaks urine at relatively low pressures. Patients with this sort of incontinence are candidates for collagen implant therapy. Collagen is injected in the region of the bladder neck with success, depending on the precise placement of the collagen. There is generally a need to implant more collagen into men. The percentage of patients showing improvement in their incontinence after therapy is 58-100%. Over time the collagen is absorbed and there is a need to repeat the treatment. Collagen increases the abdominal leak-point pressure without reducing the flow rate or increasing the residual volume. Treatment failure does not prevent the performance of other procedures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372582     DOI: 10.1007/bf02202016

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  11 in total

1.  Collagen implants in the human larynx. Pathological examinations of two cases.

Authors:  M Remacle; E Marbaix
Journal:  Arch Otorhinolaryngol       Date:  1988

2.  Improved needle placement technique in periurethral collagen injection.

Authors:  D E Neal; M E Lahaye; D C Lowe
Journal:  Urology       Date:  1995-05       Impact factor: 2.649

3.  Periurethral injection of collagen in the treatment of intrinsic sphincteric deficiency in the female patient.

Authors:  J C Winters; R Appell
Journal:  Urol Clin North Am       Date:  1995-08       Impact factor: 2.241

4.  Transurethral collagen injections in the therapy of post-radical prostatectomy stress incontinence.

Authors:  J M Cummings; J A Boullier; R O Parra
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

5.  Para-urethral collagen implantation for female stress incontinence.

Authors:  S D Eckford; P Abrams
Journal:  Br J Urol       Date:  1991-12

6.  Endoscopic implantation of collagen (GAX) for the treatment of urinary incontinence.

Authors:  H Kieswetter; M Fischer; L Wöber; J Flamm
Journal:  Br J Urol       Date:  1992-01

7.  Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence.

Authors:  G J Faerber
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

8.  Injectable collagen for type 3 female stress incontinence: the first 50 Australian patients.

Authors:  P Stricker; B Haylen
Journal:  Med J Aust       Date:  1993-01-18       Impact factor: 7.738

9.  Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up.

Authors:  A K Monga; D Robinson; S L Stanton
Journal:  Br J Urol       Date:  1995-08

10.  Collagen injection for intrinsic sphincteric deficiency in men.

Authors:  S R Aboseif; H E O'Connell; A Usui; E J McGuire
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

View more
  4 in total

1.  Factors influencing the long-term success of periurethral collagen therapy in the office.

Authors:  Sumana Koduri; Roger P Goldberg; Christina Kwon; Deborah G Dobrez; Peter K Sand
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-14

2.  Where should bulking agents for female urodynamic stress incontinence be injected?

Authors:  Annette Kuhn; Werner Stadlmayr; Daniela Lengsfeld; Michel D Mueller
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

3.  Long-term results and patients' satisfaction after transurethral ethylene vinyl alcohol (Tegress) injections: a two-centre study.

Authors:  Annette Kuhn; Werner Stadlmayr; Amara Sohail; Ash Monga
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-23

4.  Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats.

Authors:  Ehab A Elzayat; Gilles Karsenty; Tarek A Bismar; Jacques Corcos
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.